The Early Drug Discovery Doctoral Program (EDDDP) of the Center of Pharmaceutical Sciences at University of Vienna aims to provide state-of-the-art education in the field of preclinical drug research.
A major focus is devoted to developing methods for
i) computer-assisted identification of new hit compounds from natural sources affecting key components
of the metabolic network
ii) characterizing their pharmacological/toxicological profile in order to assess their molecular mode of action, and
iii) exploring their use as tool compounds in animal models of metabolic disease for target-oriented interventions.
The PhD students will highly benefit from working in strongly interconnected projects. Methods offered range from in silico screening up to in vivo experiments, thus providing a unique opportunity to be exposed to all major techniques pursued in early drug discovery programs.
Prof. Thierry Langer (Coordinator)